FDA Inspection
CXL-USA, LLCCXL-USA, LLC – FDA Inspection, Aug 19, 2014
Record Details
This FDA Inspection record concerns CXL-USA, LLC, with an inspection on August 19, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- CXL-USA, LLC
- Inspection Date
- August 19, 2014
- Product Type
- Drugs
View Company Profile
ID · a88073f0-8b9b-4bb8-acb0-950ed3c1e9cd
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 891633
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.53(c)(1)Investigator statement (FDA 1572)
- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.20(b)Starting a study before IND is in effect
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CXL-USA, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 17, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for CXL-USA, LLC
- FDA Inspection 1001620 - 2017-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.